Effect of Beta- and Alpha-Carotene Intake on Tumour Formation in the Intestines of APCMin/+ Mice
Carotene-rich vegetables like carrots have been consistently associated with lowered cancer risk in observational studies(1). Beta-carotene, a phytochemical found in fruits and vegetables, is known for its antioxidant properties. In rodent trials, supplementation with carrot (containing both caroten...
Gespeichert in:
Veröffentlicht in: | Proceedings of the Nutrition Society 2024-11, Vol.83 (OCE4) |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Carotene-rich vegetables like carrots have been consistently associated with lowered cancer risk in observational studies(1). Beta-carotene, a phytochemical found in fruits and vegetables, is known for its antioxidant properties. In rodent trials, supplementation with carrot (containing both carotenes and polyacetylenes) significantly reduced tumour numbers in the APCMin/+ mouse model(2). However, human intervention trials with pure beta-carotene showed more adverse effects than benefits(3). This study aimed to investigate the impact of beta- and alpha-carotene supplementation (without polyacetylenes) on colorectal cancer using the APCMin/+ mouse model, which spontaneously develops intestinal tumours and an enlarged liver(4). APCMin/+ mice were fed either a daily supplement of 10mg/kg mouse of a polyacetylene-free extract from carrots containing a beta- and alpha-carotene mixture, in a dose corresponding to the beneficial carrot supplementation, or the control diet, with a very low beta-carotene content (providing approx. 0.02mg/kg mouse/day). The 8-week supplementation commenced at 5 weeks of age. Tumour quantification in the small intestines of APCMin/+ mice was performed by histology of the entire small intestine, with one slide per 0.3mm, using the H&E staining method and Imagescope software. Supplementation with carotenes had no significant effect on the total number of tumours (≥0.5 mm), showing no discernible difference between the control (n = 6) (20.5, 95% CI [14.69, 26.31]) and treatment (n = 8) (24.5, [19.21, 29.79]) group (P = 0.237). However, the liver weight, in % of body weight, showed a significant 25% decrease in the treatment group (n = 7) (4.78 95% CI [4.45, 5.15]) compared to controls (6.42, [5.71, 7.13]) (P |
---|---|
ISSN: | 0029-6651 1475-2719 |
DOI: | 10.1017/S0029665124006591 |